Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Singular Genomics Systems, Inc. Common Stock (OMIC)

Laboratory Analytical Instruments

https://www.singulargenomics.com

Singular Genomics Systems Inc is a life science technology company that is leveraging novel next generation sequencing and multiomics technologies to build products that empower researchers and clinicians. The product development pipeline comprises two initial integrated solutions, each designed to leverage Sequencing Engine and purpose built to address different applications. The G4 Sequencing Platform is designed to target the NGS market. The PX Integrated Solution is designed to target the single cell, spatial analysis and proteomics markets. Both integrated solutions are used in many different and diverse market segments, including basic biology, oncology, immunology, neurology, genetic diseases, infectious diseases, the human microbiome and many others.

3010 SCIENCE PARK ROAD
SAN DIEGO, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

05/27/2021

Market Cap

17,937,023

Shares Outstanding

73,390,000

Weighted SO

73,384,510

Total Employees

N/A

Upcoming Earnings

08/14/2024

Beta

1.3590

Last Div

0.0000

Range

6.78-19.8

Chg

0.0372

Avg Vol

6035

Mkt Cap

17937023

Exch

NASDAQ

Country

US

Phone

858 333 7830

DCF Diff

8.0903

DCF

-0.9031

Div Yield

0.0000

P/S

6.5896

EV Multiple

-0.7105

P/FV

3.8841

Div Yield %

0.0000

P/E

-5.8210

PEG

-0.2328

Payout

0.0000

Current Ratio

8.7741

Quick Ratio

8.0399

Cash Ratio

1.7770

DSO

177.6727

DIO

816.3455

Op Cycle

994.0182

DPO

98.2869

CCC

895.7313

Gross Margin

-1.0437

Op Margin

-36.5437

Pretax Margin

-33.7572

Net Margin

-33.7572

Eff Tax Rate

-0.0510

ROA

-0.4177

ROE

-0.5466

ROCE

-0.4899

NI/EBT

1.0000

EBT/EBIT

0.9237

EBIT/Rev

-36.5437

Debt Ratio

0.0789

D/E

0.1261

LT Debt/Cap

0.0441

Total Debt/Cap

0.1119

Int Coverage

-174.5123

CF/Debt

-4.4623

Equity Multi

1.5976

Rec Turnover

2.0543

Pay Turnover

3.7136

Inv Turnover

0.4471

FA Turnover

0.0391

Asset Turnover

0.0124

OCF/Share

-1.0408

FCF/Share

-1.0479

Cash/Share

1.7899

OCF/Sales

-28.4555

FCF/OCF

1.0068

CF Coverage

-4.4623

ST Coverage

-7.0395

CapEx Coverage

-146.6970

Div&CapEx Cov

-146.6970

P/BV

3.8841

P/B

3.8841

P/S

6.5896

P/E

-5.8210

P/FCF

-0.2300

P/OCF

-6.9055

P/CF

-6.9055

PEG

-0.2328

P/S

6.5896

EV Multiple

-0.7105

P/FV

3.8841

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Feb 05, 23:00 $HAREHOLDER ALERT: The M&A Class Action Firm Encourages Stockholders of OMIC, BERY, WMPN, ALVR to Act Now GlobeNewswire Inc. Jan 02, 22:30 $HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating the Merger – NEUE, OMIC, JWN, DESP GlobeNewswire Inc. Dec 28, 17:13 SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates JWN, OMIC, LTRPA on Behalf of Shareholders Benzinga Sep 19, 21:24 Singular Genomics Receives Non-Binding Acquisition Proposal from Concentra Biosciences and Tang Capital GlobeNewswire Inc. Sep 19, 21:24 Singular Genomics Receives Non-Binding Acquisition Proposal from Concentra Biosciences and Tang Capital GlobeNewswire Inc. Jan 07, 17:00 Singular Genomics Reports Instrument Shipments and Preliminary Unaudited Fourth Quarter 2023 Revenue GlobeNewswire Inc. Jan 07, 17:00 Singular Genomics Reports Instrument Shipments and Preliminary Unaudited Fourth Quarter 2023 Revenue GlobeNewswire Inc. Jan 07, 17:00 Singular Genomics Reports Instrument Shipments and Preliminary Unaudited Fourth Quarter 2023 Revenue GlobeNewswire Inc. Jan 07, 17:00 Singular Genomics Reports Instrument Shipments and Preliminary Unaudited Fourth Quarter 2023 Revenue GlobeNewswire Inc. Jan 07, 17:00 Singular Genomics Reports Instrument Shipments and Preliminary Unaudited Fourth Quarter 2023 Revenue GlobeNewswire Inc. Jan 07, 17:00 Singular Genomics Reports Instrument Shipments and Preliminary Unaudited Fourth Quarter 2023 Revenue GlobeNewswire Inc. Jan 07, 17:00 Singular Genomics Reports Instrument Shipments and Preliminary Unaudited Fourth Quarter 2023 Revenue GlobeNewswire Inc. Jan 07, 17:00 Singular Genomics Reports Instrument Shipments and Preliminary Unaudited Fourth Quarter 2023 Revenue GlobeNewswire Inc. Jan 07, 17:00 Singular Genomics Reports Instrument Shipments and Preliminary Unaudited Fourth Quarter 2023 Revenue GlobeNewswire Inc. Jan 07, 17:00 Singular Genomics Reports Instrument Shipments and Preliminary Unaudited Fourth Quarter 2023 Revenue

Revenue Product Segmentation